Short Description
Trelegy Ellipta 100 mcg/62.5 mcg/25 mcg is a combination maintenance inhaler containing fluticasone furoate, umeclidinium and vilanterol. It is used to help manage chronic obstructive pulmonary disease (COPD) and, in certain adults, asthma by reducing airway inflammation and helping keep the airways open.
What Is Trelegy Ellipta 100 mcg/62.5 mcg/25 mcg?
Trelegy Ellipta contains three active ingredients: fluticasone furoate, an inhaled corticosteroid; umeclidinium, a long-acting muscarinic antagonist; and vilanterol, a long-acting beta₂-agonist. Together, they help reduce inflammation and relax the muscles around the airways.
This inhaler is used as regular maintenance treatment for certain adults with COPD or asthma, depending on their condition and local prescribing guidance. It is not intended to provide immediate relief during a sudden breathing emergency.
Uses
Trelegy Ellipta 100 mcg/62.5 mcg/25 mcg may be prescribed to:
Manage chronic obstructive pulmonary disease (COPD).
Maintain asthma control in adults when this combination is appropriate for their treatment.
Help reduce airway inflammation and improve airflow as part of ongoing respiratory treatment.
The appropriate treatment and dose should be determined by a healthcare professional based on the patient's condition, previous treatment and applicable local guidance.
How Does Trelegy Ellipta Work?
Trelegy Ellipta combines three medicines that work in different ways:
Fluticasone furoate reduces inflammation in the airways.
Umeclidinium blocks muscarinic receptors, helping relax the muscles around the airways.
Vilanterol stimulates beta₂ receptors, helping the airway muscles relax and making breathing easier.
Together, these actions help maintain open airways and control respiratory symptoms with regular use. The inhaler is intended for ongoing treatment rather than sudden episodes of breathlessness.
How to Take Trelegy Ellipta
Take Trelegy Ellipta exactly as prescribed by your healthcare professional.
It is generally used as one inhalation once daily, at approximately the same time each day, unless your prescriber gives different instructions.
Use it by oral inhalation through the Ellipta device. Follow the device instructions and ask a healthcare professional to demonstrate the correct technique if needed.
Rinse your mouth with water after inhaling and spit it out to help reduce the risk of oral thrush.
Do not use extra doses or stop treatment without consulting your healthcare professional.
If you miss a dose, take the next dose at the usual time the following day. Do not take more than one dose in 24 hours.
Important Safety Information
Tell your doctor or pharmacist about your medical history and all medicines, vitamins, supplements and herbal products you use before starting Trelegy Ellipta.
Use particular caution and seek medical advice if you have:
A history of severe allergy to any ingredient in the inhaler or to milk proteins, as the inhaler contains lactose that may contain milk protein.
Heart disease, an irregular heartbeat or high blood pressure.
Glaucoma or difficulty passing urine, including problems related to an enlarged prostate.
Diabetes, seizures, thyroid disorders, liver disease or a history of tuberculosis or other infections.
A history of recurrent chest infections or osteoporosis.
Trelegy Ellipta may interact with other inhaled medicines, particularly other long-acting bronchodilators or anticholinergic medicines. Interactions may also occur with certain beta-blockers, diuretics, some antidepressants and medicines that affect the CYP3A4 enzyme, such as ketoconazole.
Trelegy Ellipta is not a rescue inhaler for sudden breathing difficulties. Follow your prescribed emergency plan and seek urgent medical help if breathing suddenly worsens or does not improve with your reliever medicine. Check potential interactions and precautions with your doctor or pharmacist.
Pregnancy & Breastfeeding
There is limited information about the use of Trelegy Ellipta during pregnancy and breastfeeding. It should be used during pregnancy only when a healthcare professional considers that the expected benefits outweigh potential risks. It is not known with certainty whether its active ingredients pass into breast milk.
If you are pregnant, planning a pregnancy or breastfeeding, speak with your doctor before using this inhaler. Do not stop prescribed respiratory treatment without professional advice.
Side Effects
Like all medicines, Trelegy Ellipta can cause side effects, although not everyone experiences them.
Common or reported side effects may include:
Headache.
Cough, sore throat or hoarse voice.
Oral thrush (a fungal infection in the mouth or throat).
Cold-like symptoms or upper respiratory tract infections.
Constipation or dry mouth.
Joint or back pain.
Seek prompt medical attention for severe allergic reactions, sudden worsening of breathing immediately after inhalation, chest pain, a rapid or irregular heartbeat, eye pain or sudden changes in vision, or symptoms that may indicate pneumonia, such as fever with worsening cough or breathing difficulties.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Storage
Store Trelegy Ellipta according to the instructions shown on the original product packaging.
Keep the inhaler in its original packaging until it is ready to use, where instructed.
Protect it from excessive heat, moisture and direct sunlight.
Keep it out of the reach of children.
Do not use the inhaler after its expiry date or beyond the in-use period stated in the patient information leaflet.
Storage conditions and the period for using an opened inhaler may vary by market and product packaging. Refer to the supplied leaflet for the exact instructions.